
Fight for your rights
Join the Coverage2Control campaign, and tell insurance companies to provide affordability, choice and coverage to help people with type 1 diabetes (T1D) better control the disease.
Take the employer survey
JDRF wants to help employers improve their benefits structure. Take this survey to see how you could help.
What is #Coverage2Control?
JDRF is calling on insurers, employers, drug companies and the government to provide these three things that will help people with type 1 diabetes (T1D) control the disease.
Affordability
Make out-of-pocket insulin and other costs predictable and reasonable.
Choice
Give people the freedom to choose the insulin pump thatās right for them.
Coverage
Cover all life-saving technology, including the artificial pancreas.

Impact So Far
Weāre making your voice heard where #Coverage2Control decisions are made ā at insurance companies, employers, and at the U.S. Department of Health & Human Services.
Thousands of messages to insurers
50,000+ people signed the #Coverage2Control petition and 12 major groups signed on as partners. JDRF hand-delivered your petitions to the 25 largest health insurance companies, and supporters sent thousands of personalized follow-up messages.
Artificial pancreas systems covered
All 25 of the nationās largest health plans now cover artificial pancreas systems, including Anthem, which reversed its policy after hearing from JDRF and the T1D community.
Progress toward lower insulin costs
In 2018 UnitedHealthcare announced it would extend the drug discounts it receives to its members in fully insured commercial plans.Ā Pressure from the campaign prompted Aetna and Blue Cross Blue Shield of North Carolina to do so as well. Ā UnitedHealthcare then expended its program further, announcing that in 2020 all new employer plans would have to pass drug discounts through to the people who need the drugs.
JDRF has additionally called for drug companies to lower list prices and do more to help the uninsured access affordable insulin, and continues to be involved in ongoing conversations. JDRF continues to be deeply involved in ongoing conversations with Congress and the Administration about this important topic. Read our Congressional Testimony here.
Strongly Oppose Restrictions
After UnitedHealthcare announced it was extending its preferred insulin pump agreement to children as young as 7, we met with company leaders to urge them to reconsider this decision. Since then, weāve encouraged our community to send a message to UHC that insurance restrictions like these are bad for people with T1D and our health system and tens of thousands of letters have been sent in as a result.Ā Your voices were heard ā on July 1, 2020 UHC revised their policy.

Spread the word
Materials and information to help you educate others.
Growing Support
Learn more about why JDRF is telling insurance companies to provide coverage that works for people with T1D.
See Whatās at Stake
See why choice is so important for people with T1D, especially when it comes to choosing an insulin pump.
What JDRF is Fighting For
JDRF plays an important role in accelerating innovation and ensuring access for all Americans with T1D.
Our Partners
Thanks to our partners fighting for #Coverage2Control












